TGFB1 and rheumatoid arthritis: For example, Iguratimod, an antirheumatic drug approved for rheumatoid arthritis in Japan and China, was found to effectively reduce renal interstitial fibrosis and tubular atrophy inhibiting collagen fibers deposition and blocking EMT through interference with TGF-β/Smad signaling [105].